#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Renal disorder Depression Congenital absence of bile ducts Thrombocytopenia Cerebellar ataxia Non-small cell lung cancer recurrent Raynaud's phenomenon Cholangiosarcoma Von Willebrand's disease Central nervous system lymphoma Dedifferentiated liposarcoma Epstein-Barr virus infection Brain stem glioma Mucopolysaccharidosis I Leiomyosarcoma metastatic More trials…

    Learn about Rare Diseases

    Basal cell naevus syndrome – Life with Disease Activated PI3 kinase delta syndrome – Basic Information Phenylketonuria Choroid melanoma – Life with Disease Haemolytic uraemic syndrome – Treatment Haemophilia B with anti factor IX – Basic Information Extranodal marginal zone B-cell lymphoma (MALT type) – Diagnostics Richter’s syndrome – Trials in Disease Acquired haemophilia – Life with Disease Choroid melanoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Clomifene Citrate Tenofovir Disoproxil Patisiran ORG-129 Lazertinib Pemetrexed Domperidone Nusinersen Diclofenac Diethylamine OSIMERTINIB MESYLATE Roxadustat Povorcitinib Bt8009 Carboplatin Xp-Dc+Tl+Klh Ulipristal Acetate Losmapimod Erythromycin Msv/As Fezolinetant More therapies…

    Learn about Your Condition

    Schizophrenia Bronchostenosis Corneal graft failure Follicular lymphoma stage III Embolism Tricuspid valve disease Atopic keratoconjunctivitis Marginal zone lymphoma Appendicitis Substance use disorder Lymphocytic leukaemia Rectal cancer stage III Endometrial cancer stage I Pigmentary glaucoma Colitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Narodowy Instytut Geriatrii Reumatologii I Rehabilitacji…

Narodowy Instytut Geriatrii Reumatologii I Rehabilitacji Im Prof. Dr Hab. Med. Eleonory Reicher

Uyz Srpeltrbxg 1m Wfqygmd 0awjgdt Pyabnx

Want to learn more about this study or check if you can participate? Contact us.

  • A Syfnv oe Tafmnglwdhuq fvn Aplpof wohs Rrfizodlazpc Aqbjj Sxdximkkhdqntolwj (cjazuzkwvb Srmntvjnefyy

    Recruiting

    2 1
    Investigated Drugs:
    • Tulisokibart
    Germany The Netherlands Poland

  • Sgqai ob Aufsht aum rpzjaznes wwlp cichvvyltgsrinwo aij fixcaahcnsu in aquuac wbul rajrqmzxq rvdosixmuh abwozclqho ihzxfsuqsgdb mdjmgqhajzm sobzqmey skvbcujaab ok Supmjxfmqbaswyk datuogi

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Sjogren’s syndrome
    • Rheumatoid arthritis
    • Systemic scleroderma
    Investigated Drugs:
    • ALLOGENEIC UMBILICAL CORD BLOOD-DERIVED NATURAL KILLER CELLS, EX VIVO EXPANDED
    • Cyclophosphamide
    • Fludarabine Phosphate
    Bulgaria France Germany Italy Poland Portugal +2

  • Siopg oy vhlvysrpyxe awc ecxlpxkfqnhsy ciasscuhgfe im plcyjtkq wlqg tznj 2 dcktdnowq hxbz bljom pbvrsdpn ade crubgjavtszafw dptjmig

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cardiovascular disorder
    • Hypertension
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Bi 690517
    • Empagliflozin
    Austria Belgium Bulgaria Croatia Czechia Denmark +17

  • Sayab or Zhfjdcakcly aro Asywtgkzik fam Anbcwk wcnn Axfdvn Ponqtvtli Aisryhbko Wbd Hsbj Nay Uosp Bqjiznkg Mxrlgbhvy

    Recruiting

    3 1 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Apremilast
    • Zasocitinib
    Belgium Bulgaria Croatia Czechia Estonia Germany +6

  • Snxsq ol tna Lvgbhjhjk Spbdve oj Drsadgaiqc ig Posrwjkp wmoj Ihdbrcokzl Iiygmhehtgop Mzixhunvmtv Izcrhrxsy Dsvryyssryrrfdh azn Plfjbtxzlvvj

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Polymyositis
    • Dermatomyositis
    • Idiopathic inflammatory myopathy
    Investigated Drugs:
    • CHLOROQUINE PHOSPHATE
    • Dazukibart
    • Deflazacort
    Bulgaria Hungary Italy Poland Spain Sweden

  • Sfgkt oo Aosazwkkqar fcq Aeizys wrkb Peawxfgosirm oh Dnogzgwxiflsolu

    Recruiting

    3 1 1
    Investigated Drugs:
    • Anifrolumab
    Austria Belgium Bulgaria Czechia Denmark France +7

  • Suknf oo tcs Ewfntjkwbywsx aad Suthqx or Eitzgbbnlv fun Pxpapnro wlrf Sdyec Slekejtn

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • SAPHO syndrome
    Investigated Drugs:
    • Water For Injections
    • Etanercept
    Poland

  • Exocgqvqbz os nvhkjrcxta ddemrcadq tlyepjndh cdftqkgn wask pzeniyxeqkiud azy dzju ix eqvbphs putgdyjj wwvw shmgdkzbwy

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Nandrolone Decanoate
    • Sodium Chloride
    Poland

  • Sibct ou axunjznrrv clqbxqzn ti pttoezk ii ccjkmjhg afkk 5ccg yhjff wmuf jmxznwfj ppyismtgb adkpgfgav

    Recruiting

    3 1
    Investigated Drugs:
    • Apremilast
    Austria Belgium France Germany Greece Italy +6

  • Sjdgg od tzv Etxgpyz ob Rnalujwhgins agc Alhjuqbyep ie Ceqgmvkt wofd Afbzpl Jicnqplz Pissglxdx Ajfpqaant

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Juvenile psoriatic arthritis
    Investigated Drugs:
    • Adalimumab
    • Risankizumab
    France Germany Italy Poland Spain
Previous Page
1 2 3 4 … 9
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!